Skip to main content
Caplight Logo









Zoe Biosciences

Zoe Biosciences

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://zoebiosciences.com/

Last Round

Seed

Mar 31, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Zoe Biosciences is a biotechnology company developing best-in-class therapies to treat cardiometabolic disease by targeting molecular pathways linked to cellular senescence and metabolic dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

longevity biotechdrug discoverycardiometabolic diseasecellular senescencePAI-1 inhibitorsanti-aging therapeuticsgerosciencemonoclonal antibodiessmall molecule drugsAPJ agonistspreclinical biotechpharma licensinggenetic target validationmetabolic dysfunction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zoe Biosciences Comparables

Compare Zoe Biosciences with similar companies based on industry and business-model similarity.

Zoe Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rubedo Life Sciences
74%
Anodyne Nanotech
73%
BioAge Labs
73%

Zoe Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 31, 2023

Key People

Founding team and executive leadership

Scott Gies

CEO & Cofounder

Founding Team

Zoe Biosciences Investors

Notable investors and investment history

Zoe Biosciences investors
InvestorRounds
Longevitytech.fundPre Seed
VitaDAOSeed
Healthspan CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 41% MoM, reaching 1.6K.

  • Mar 2, 2026

    Monthly visitors grew 192% MoM, reaching 1.2K.

Zoe Biosciences Filings

Explore SEC and related filing metadata, where available.

Zoe Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zoe Biosciences's valuation, stock price, and market status.

Is Zoe Biosciences a public or private company?

Zoe Biosciences is a private company.

What is the current stock price of Zoe Biosciences?

Zoe Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Zoe Biosciences worth (valuation)?

Valuation information for Zoe Biosciences is not publicly available.

Can I buy Zoe Biosciences stock?

Zoe Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zoe Biosciences's last funding round?

Funding round information for Zoe Biosciences is not publicly available.

Who are the main investors in Zoe Biosciences?

Investor information for Zoe Biosciences is not publicly disclosed.

Will Zoe Biosciences IPO soon?

No public IPO plans have been announced for Zoe Biosciences.

How can I track Zoe Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zoe Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range2
Year Founded2021
Last FundingMar 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?